Clinical trial
Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
NCT01203345 is registered in ClinicalTrials.gov with NICHD Neonatal Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants
- Lead sponsor
- NICHD Neonatal Research Network
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 31, 1988
- Completion date
- March 31, 1991
- Enrollment
- 2,416 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
infant, low birth weight, infant, newborn, infant, premature, infant, small for gestational age, sepsis